TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34820147

Group type: EXPERIMENTAL
Intervention: SpHb monitoring
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (surgeons’ experience)
Number of subjects: 150
Study: 35151559

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular olanzapine
Number of subjects: 0
Study: 34453212

Group type: EXPERIMENTAL
Intervention: Postoperative intravenous somatostatin (250 μg/h over 120 h); n=99
Number of subjects: 199
Study: 35785965

Group type: COMPARATOR
Intervention: Guideline-based regular exercise (EXE)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Guideline-based regular exercise and 15-minute post-exercise sauna (EXS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 47
Study: 34278884

Group type: EXPERIMENTAL
Intervention: 3NB (combined suprascapular, axillary nerve, and the articular branch of lateral pectoral nerve block)
Number of subjects: 85

Group type: COMPARATOR
Intervention: ISB (interscalene nerve block)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 3NB
Number of subjects: 85
Study: 34010221

Group type: EXPERIMENTAL
Intervention: Capillary pull technique
Number of subjects: 118

Group type: COMPARATOR
Intervention: Suction technique
Number of subjects: 118
Study: 34941128

Group type: EXPERIMENTAL
Intervention: 50 mL of a 2% saline solution for bilateral nasal irrigation for 1 week, followed by 50 mL of a 0.9% normal saline solution for bilateral nasal irrigations.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine guidance and 20 mL of normal saline atomized through inhalation.
Number of subjects: 60
Study: 36271928

Group type: EXPERIMENTAL
Intervention: Active tDCS (anode F3 and cathode F4; 2 mA intensity) and an action-like video game
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham tDCS and a control video game
Number of subjects: 114
Study: 33413355

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34045632

Group type: EXPERIMENTAL
Intervention: Ozone method (20 s of ozone from the healozone X4)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional method (complete caries removal)
Number of subjects: 84
Study: 36099230

Group type: EXPERIMENTAL
Intervention: Dilute Silver Diamine Fluoride (1:10)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Light Cure Calcium Hydroxide
Number of subjects: 56
Study: 32365398

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 35621282

Group type: EXPERIMENTAL
Intervention: Modified Iliotibial Band Tenodesis (MITBT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Lateral Extracapsular Tenodesis (LET)
Number of subjects: 164
Study: 32314120

Group type: EXPERIMENTAL
Intervention: Text message reminders and data-informed counseling through 3 months postpartum
Number of subjects: 133

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 133
Study: 35039254

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine Paishi decoction combined with laparoscopic ureterectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic ureterectomy
Number of subjects: 100
Study: 32494981

Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP)
Number of subjects: 47

Group type: COMPARATOR
Intervention: capecitabine plus cisplatin (XP)
Number of subjects: 47
Study: 35129503

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)‐guided lumen‐apposing metal stent (LAMS) with protocolized necrosectomy
Number of subjects: 40
Study: 32578466

Group type: EXPERIMENTAL
Intervention: LVA ablation (group B, n=30)
Number of subjects: 398

Group type: COMPARATOR
Intervention: No LVA ablation (group C, n=32)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: LVA ablation (group B)
Number of subjects: 398

Group type: COMPARATOR
Intervention: No LVA ablation (group C)
Number of subjects: 398
Study: 32425134

Group type: EXPERIMENTAL
Intervention: Plastic cannula (17-gauge inner needle)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Metal needle (16-gauge)
Number of subjects: 16
Study: 32969562

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Coding training (active control)
Number of subjects: 100
Study: 35279754

Group type: EXPERIMENTAL
Intervention: Attendance promotion intervention
Number of subjects: 2010

Group type: COMPARATOR
Intervention: Self-employed participants
Number of subjects: 2010
Study: 33328160

Group type: EXPERIMENTAL
Intervention: Glycemic excursion minimization (GEM)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional weight loss (WL)
Number of subjects: 178
Study: 35508200

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-exercise condition
Number of subjects: 12
Study: 34703056

Group type: EXPERIMENTAL
Intervention: ultrasound guided SCPB with 5 mL ropivacaine 0.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group 'No block'
Number of subjects: 30
Study: 35971066

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - comprehensive assessment of physiological and psychological functioning, individual digital treatment program based on assessment needs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active Control Group (ACG) - common digital treatment program aiming to reduce PACS symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison Group (CompG) - no treatment
Number of subjects: 0
Study: 33890902

Group type: EXPERIMENTAL
Intervention: Nile tilapia fish skin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Silver sulfadiazine cream 1%
Number of subjects: 115
Study: 32379676

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise + Massage (AM)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Massage (M)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 39
Study: 34374434

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with adjunctive amoxicillin (500 mg) and metronidazole (200 mg) three times a day for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 14
Study: 34110746

Group type: EXPERIMENTAL
Intervention: Combination oral nitroimidazole 500 mg twice a day for 7 days and simultaneous boric acid 600 mg daily per vagina for 30 days, followed by twice-weekly vaginal metronidazole gel for 5 months.
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Maintenance metronidazole gel
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 105
Study: 32383271

Group type: EXPERIMENTAL
Intervention: THC (7.0% THC/0.18% CBD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CBD (0.4% THC/10.4% CBD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (0% THC/0% CBD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All conditions (THC, CBD, Placebo)
Number of subjects: 14
Study: 36226961

Group type: EXPERIMENTAL
Intervention: Trial Group (TG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No Trial Group (NTG)
Number of subjects: 66
Study: 33581770

Group type: EXPERIMENTAL
Intervention: Collegial leadership practices/characteristics
Number of subjects: 3208

Group type: EXPERIMENTAL
Intervention: Baseline collegial leadership
Number of subjects: 3208
Study: 32903261

Group type: EXPERIMENTAL
Intervention: Oral stimulation program (tactile extra-, peri-, and intraoral manipulation) once a day for 15 minutes over 10 days
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Oral stimulation program
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Breast milk intake
Number of subjects: 74
Study: 616901046

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) such as rivaroxaban and edoxaban
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 35483708

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33494795

Group type: EXPERIMENTAL
Intervention: Acetate Ringer’s solution
Number of subjects: 312

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 312
Study: 34032376

Group type: EXPERIMENTAL
Intervention: Passive pedaling with mini bike, 20 min, twice a week for 3 months
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37
Study: 32661707

Group type: EXPERIMENTAL
Intervention: 3D-vision
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2D-vision
Number of subjects: 20
Study: 34157617

Group type: EXPERIMENTAL
Intervention: OxCapRT (oxaliplatin 85 mg/m2 on Days 1, 15, and 29; capecitabine 625 mg/m2 orally twice daily on days of radiotherapy)
Number of subjects: 85

Group type: COMPARATOR
Intervention: CarPacRT (carboplatin AUC2; paclitaxel 50 mg/m2 on Days 1, 8, 15, 22, and 29)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: OxCapRT
Number of subjects: 85

Group type: COMPARATOR
Intervention: CarPacRT
Number of subjects: 85
Study: 32080093

Group type: EXPERIMENTAL
Intervention: Deep learning model for preoperative diagnosis of PM in gastric cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: CT imaging (initial diagnosis as PM negative)
Number of subjects: 0
Study: 35231721

Group type: EXPERIMENTAL
Intervention: ABRACADABRA instruction (16 hours over 8 weeks) with supplementary parent-led shared book reading
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study: 37086227

Group type: COMPARATOR
Intervention: No postprocedure prophylaxis (standard of care arm, group A)
Number of subjects: 139
Study: 34656193

Group type: EXPERIMENTAL
Intervention: Exposure-only (EXP+EXP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cognitive strategies followed by exposure (COG+EXP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Relaxation strategies followed by exposure (REL+EXP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: All conditions (EXP+EXP, COG+EXP, REL+EXP)
Number of subjects: 65
Study: 32123973

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 35436940

Group type: EXPERIMENTAL
Intervention: Nimodipine (60 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 33
Study: 32167226

Group type: EXPERIMENTAL
Intervention: Custom-made PEKK posts
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional fiber posts
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prefabricated PEKK posts
Number of subjects: 30
Study: 34751384

Group type: EXPERIMENTAL
Intervention: Nanofibrous polymer‐based matrix
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (standard of care such as Jelonet® or Biatain® Ibu dressing)
Number of subjects: 41
Study: 33300239

Group type: EXPERIMENTAL
Intervention: Active, mandible protruded oral appliance (OAa)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Passive, mandible non‐protruded device (OAp)
Number of subjects: 71
Study: 32475182

Group type: EXPERIMENTAL
Intervention: Voluntary‐induced stepping response training (VSR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: DynSTABLE perturbation training (DST)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both VSR and DST
Number of subjects: 34
Study: 33983961

Group type: EXPERIMENTAL
Intervention: Targeted kinesio taping applied once a week for four sessions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo taping application
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Targeted kinesio taping
Number of subjects: 62
Study: 32894540

Group type: EXPERIMENTAL
Intervention: Leptin (Lep) at concentrations of 5-320 ng/mL
Number of subjects: 0
Study: 35896277

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor–based therapy (fixed combination of perindopril and indapamide)
Number of subjects: 9694

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9694

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor–based therapy
Number of subjects: 9694
Study: 33871411

Group type: EXPERIMENTAL
Intervention: Reminder SMS texts
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Real-time medication monitoring (RTMM) device (Wisepill) with SMS reminders
Number of subjects: 249

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 249
Study: 35565820

Group type: EXPERIMENTAL
Intervention: Vegetarian/Vegan diets
Number of subjects: 436178

Group type: COMPARATOR
Intervention: Omnivorous diets
Number of subjects: 436178
Study: 35530564

Group type: EXPERIMENTAL
Intervention: 0.1% TXA 1000 mg (10 mL) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Distilled water (placebo) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Number of subjects: 50
Study: 34350884

Group type: EXPERIMENTAL
Intervention: Zephyr valve
Number of subjects: 93

Group type: COMPARATOR
Intervention: SoC
Number of subjects: 93
Study: 33458967

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (exercise + education, CRP cohort, n = 125)
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Exercise only (USC cohort, n = 182)
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (exercise + education, CRP cohort)
Number of subjects: 492
Study: 36112108

Group type: EXPERIMENTAL
Intervention: Prenatal social support
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Prepregnancy OW/OB
Number of subjects: 524
Study: 33921271

Group type: EXPERIMENTAL
Intervention: Loving-Kindness Meditation (LKM) training for 8 weeks
Number of subjects: 106

Group type: COMPARATOR
Intervention: Waiting control group (no intervention)
Number of subjects: 106
Study: 32453168

Group type: EXPERIMENTAL
Intervention: Femoral nerve catheters placed perpendicular to the nerve (Group 1, n=40)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Femoral nerve catheters placed parallel to the nerve (Group 2, n=38)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 78
Study: 34975041

Group type: EXPERIMENTAL
Intervention: New material radial echoendoscope
Number of subjects: 130

Group type: COMPARATOR
Intervention: Existing endoscope
Number of subjects: 130
Study: 33495919

Group type: EXPERIMENTAL
Intervention: Nafamostat mesylate (NM) 20 mg
Number of subjects: 441

Group type: COMPARATOR
Intervention: Non-Nafamostat mesylate (non-NM)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Nafamostat mesylate (NM)
Number of subjects: 441
Study: 33054259

Group type: EXPERIMENTAL
Intervention: Broiler chickens
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Free-range chickens
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Molecular detection
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis
Number of subjects: 342
Study: 35938913

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase before endovascular treatment
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Combination therapy (alteplase + endovascular treatment)
Number of subjects: 654

Group type: COMPARATOR
Intervention: Endovascular treatment only
Number of subjects: 654
Study: 33236611

Group type: EXPERIMENTAL
Intervention: High-intensity trunk control training plus low-intensity conventional stroke rehabilitation (45 min, once a day for 5 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-intensity conventional stroke rehabilitation (45 min, once a day for 5 days)
Number of subjects: 30
Study: 33823205

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 70

Group type: COMPARATOR
Intervention: LMA Proseal
Number of subjects: 70
Study: 33040755

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol-impregnated caps
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard practices (without alcohol-impregnated caps)
Number of subjects: 16
Study: 32676897

Group type: EXPERIMENTAL
Intervention: Medical students and residents classification of cases
Number of subjects: 240

Group type: COMPARATOR
Intervention: Medical students and residents versus medical specialists
Number of subjects: 240
Study: 35710447

Group type: EXPERIMENTAL
Intervention: Bilateral acupuncture or acupressure at P6
Number of subjects: 3500

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 3500
Study: 33397429

Group type: EXPERIMENTAL
Intervention: Oral Ivermectin at a single dose of 0.2 mg/kg for outpatient and inpatient groups.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Standard treatment regimen for mild and moderate COVID-19 plus Ivermectin.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hydroxychloroquine sulfate at a dose of 400 mg twice a day for the first day and 200 mg twice a day for seven subsequent days for outpatient control group.
Number of subjects: 120

Group type: COMPARATOR
Intervention: 200/50 mg Lopinavir/Ritonavir twice a day for seven days plus five doses of 44 mcg Interferon beta-1a every other day for inpatient control group.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 120
Study: 34088734

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 215
Study: 32011447

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine Shen-Qi Hua-Yu formula
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33833401

Group type: EXPERIMENTAL
Intervention: Vortioxetine (N = 184)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo (N = 97)
Number of subjects: 281
Study: 36232282

Group type: EXPERIMENTAL
Intervention: Face‐to‐face teaching with active training
Number of subjects: 142

Group type: COMPARATOR
Intervention: Non‐face‐to‐face teaching with passive training
Number of subjects: 142
Study: 32610058

Group type: EXPERIMENTAL
Intervention: Conventional a-tDCS (1 mA, 10-minutes)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Conventional c-tDCS (1 mA, 10-minutes)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HD-a-tDCS (1 mA, 10-minutes)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HD-c-tDCS (1 mA, 10-minutes)
Number of subjects: 15
Study: 33315003

Group type: EXPERIMENTAL
Intervention: Do-module (systematic self-monitoring of positive affect and activities for 28 days)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Think-module (systematic self-monitoring of negative affect and thinking patterns for 28 days)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 161
Study: 35382845

Group type: EXPERIMENTAL
Intervention: Yoga intervention (6 sessions of 45 minutes over 12 weeks)
Number of subjects: 94
Study: 33779195

Group type: EXPERIMENTAL
Intervention: Probation
Number of subjects: 347

Group type: COMPARATOR
Intervention: Prison
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Retribution justification
Number of subjects: 347
Study: 32432914

Group type: EXPERIMENTAL
Intervention: Exercise-heat acclimation (EHA) protocol for 8 days, involving 120 min of exercise at 5 km/h, 2% incline, 40°C and 40% relative humidity (RH).
Number of subjects: 13
Study: 33085021

Group type: EXPERIMENTAL
Intervention: Annular closure device (ACD) group (276 patients)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control group (CG) (278 patients)
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 554
Study: 32759183

Group type: EXPERIMENTAL
Intervention: binimetinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: physician choice chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: trametinib
Number of subjects: 0
Study: 35108791

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg for 7 days
Number of subjects: 137

Group type: COMPARATOR
Intervention: Not given tamsulosin
Number of subjects: 137
Study: 33529593

Group type: EXPERIMENTAL
Intervention: DRSS-guided management
Number of subjects: 40

Group type: COMPARATOR
Intervention: PLI-guided management
Number of subjects: 40
Study: 32088664

Group type: EXPERIMENTAL
Intervention: Slow breathing exercise (daily training for 8 weeks)
Number of subjects: 75
Study: 35365371

Group type: EXPERIMENTAL
Intervention: Sodium selenite (200 μg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Se-enriched yeast (200 μg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium selenite and Se-enriched yeast
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34398955

Group type: EXPERIMENTAL
Intervention: TAF/FTC+DTG
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: TDF/FTC+DTG
Number of subjects: 385

Group type: COMPARATOR
Intervention: TDF/FTC/EFV
Number of subjects: 385
Study: 35822881

Group type: EXPERIMENTAL
Intervention: WARM (n=10): 2 hours cycling at 50W in 34.4°C water
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HOT (n=10): 1 hour cycling against minimal resistance in 36.7°C water
Number of subjects: 20
Study: 33443719

Group type: EXPERIMENTAL
Intervention: Probiotic supplement (Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32554653

Group type: EXPERIMENTAL
Intervention: MULTIPAP intervention (GPs e-training and GP-patient-centred interview)
Number of subjects: 593

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 593
Study: 35618326

Group type: EXPERIMENTAL
Intervention: Remote home-based exercise programme monitored by phone calls
Number of subjects: 44

Group type: COMPARATOR
Intervention: Face-to-face home-based exercise programme monitored by home visits
Number of subjects: 44
Study: 32732334

Group type: EXPERIMENTAL
Intervention: EarlyCDT‐Lung test plus low‐dose CT scanning 6‐monthly for up to 2 years
Number of subjects: 12208

Group type: COMPARATOR
Intervention: Standard clinical care (control arm)
Number of subjects: 12208

Group type: EXPERIMENTAL
Intervention: EarlyCDT‐Lung test plus CT screening
Number of subjects: 12208